Disease burden of systemic light-chain amyloidosis: a systematic literature review

Huamao Mark Lin(Takeda (United States)), Parameswaran Hari(Medical College of Wisconsin), Brian Seal, Douglas V. Faller(Celsion (United States)), Xīn Gào(Qingdao University), Richard Labotka(Takeda (United States)), Deborah Berg(Millennium Engineering and Integration (United States)), Catherine E. Cooke(Pharmerit (United States))
Current Medical Research and Opinion
February 21, 2017
10.1080/03007995.2017.1297930
Cited by 32

Related Papers

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
|The Lancet|2021|1.7k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.
|Journal of Clinical Investigation|1991|688